ArticleRMD open2017

Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis.

Pierre-Antoine Juge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.